Skip to main content
Public Health Reports logoLink to Public Health Reports
. 1987 Jul-Aug;102(4):395–398.

Characteristics of drug abusers that discriminate needle-sharers.

M P Dolan, J L Black, H A Deford, J R Skinner, R Robinowitz
PMCID: PMC1477880  PMID: 3112850

Abstract

To identify variables that discriminate needle-sharing among drug abusers, 224 male drug abusers were studied. They had been admitted to a 30-day inpatient drug treatment program over a 19-month period (September 1983 through March 1985). The variables examined were divided into three categories: demographic (age, race, education), personality (Minnesota Multiphasic Personality Inventory [MMPI] scores and MMPI deviant scores), and drug use patterns (drug of choice, use of single or multiple [mixed] drugs, severity of drug use, and place of use). Three variables were identified that discriminated needle-sharers from other drug abusers. Compared with other drug abusers, needle-sharers used more multiple drugs, were more likely to use a "shooting gallery," and had more problems related to drug use. No demographic or personality variables discriminated needle-sharers from nonsharers. The data suggested that needle-sharing is widespread in the drug culture. Needle-sharing was not confined to a particular racial group, educational level, or personality type. These findings can be used to structure education programs about acquired immunodeficiency syndrome (AIDS) for drug abusers. Drug treatment programs appear to provide an important opportunity to educate drug abusers about AIDS and related health issues associated with needle-sharing.

Full text

PDF
395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black J. L., Dolan M. P., DeFord H. A., Rubenstein J. A., Penk W. E., Robinowitz R., Skinner J. R. Sharing of needles among users of intravenous drugs. N Engl J Med. 1986 Feb 13;314(7):446–447. doi: 10.1056/nejm198602133140712. [DOI] [PubMed] [Google Scholar]
  2. Des Jarlais D. C., Friedman S. R., Hopkins W. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med. 1985 Nov;103(5):755–759. doi: 10.7326/0003-4819-103-5-755. [DOI] [PubMed] [Google Scholar]
  3. Drucker E. AIDS and addiction in New York City. Am J Drug Alcohol Abuse. 1986;12(1-2):165–181. doi: 10.3109/00952998609083750. [DOI] [PubMed] [Google Scholar]
  4. Friedland G. H., Harris C., Butkus-Small C., Shine D., Moll B., Darrow W., Klein R. S. Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med. 1985 Aug;145(8):1413–1417. [PubMed] [Google Scholar]
  5. Osborn J. E. The AIDS epidemic: multidisciplinary trouble. N Engl J Med. 1986 Mar 20;314(12):779–782. doi: 10.1056/NEJM198603203141212. [DOI] [PubMed] [Google Scholar]
  6. Skinner H. A. The drug abuse screening test. Addict Behav. 1982;7(4):363–371. doi: 10.1016/0306-4603(82)90005-3. [DOI] [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES